CULVER CITY, Calif.--(BUSINESS WIRE)--
NantHealth,
Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized
healthcare company, today announced its partnership with CareSource,
a leading nonprofit multi-state health plan serving government-sponsored
programs, to bring patients value-based care through Eviti®
Connect, the evidence-based treatment intelligence and web-based
oncology decision support platform.
CareSource is a nationally recognized leader with more than 1.9 million
members across five states, and is dedicated to member-centric health
care coverage. The company’s managed care business model was founded in
1989 and is today one of the nation’s largest Medicaid managed care
plans. The partnership with NantHealth will enable CareSource members to
have the peace of mind that they are receiving the most appropriate and
cost-effective treatment.
“Supporting CareSource in their mission to improve the health and
wellbeing of their members is paramount for us,” said Ron Louks, Chief
Operating Officer of NantHealth. “We look forward to helping them
improve their claim processing efficiency, streamline the
pre-authorization process for cancer treatments and reduce denials and
appeals.”
NantHealth’s Eviti Connect is a web-based application that
electronically connects healthcare plans and oncology practices for the
authorization of treatment plans in near-real time. Eviti Connect
reduces the administrative time involved in obtaining authorizations,
assures appropriate reimbursement at the regimen level and validates
cancer treatment options. Eviti Connect is a comprehensive
evidence-based solution for oncology regimen selection that matches
provider-recommended treatment with payer plan language and medical
policy to ensure congruence.
About NantHealth
NantHealth, a member of the NantWorks
ecosystem of companies, provides leading solutions across the continuum
of care for physicians, payers, patients and biopharmaceutical
organizations. NantHealth enables the use of cutting edge data and
technology towards the goal of empowering clinical decision support and
improving patient outcomes. NantHealth’s comprehensive product portfolio
combines the latest technology in molecular analysis (GPS Cancer®
and Liquid GPS®), payer/provider platforms that exchange
information in near-real time (NaviNet and Eviti), and connected care
solutions that deliver Medical Device Interoperability (MDI).
NantHealth’s GPS Cancer® molecular profiling provides
comprehensive DNA & RNA tumor-normal profiling combined with
pharmacogenomics analysis. Liquid GPS® provides non-invasive
testing of cfDNA and cfRNA to monitor cancer mutations and potentially
select targeted therapies, chemotherapies, and immunotherapies. For more
information, please visit www.nanthealth.com
or follow us on Twitter,
Facebook
and LinkedIn.
About CareSource
CareSource is a nonprofit, multi-state
health plan recognized as a national leader in managed care. Founded in
1989, CareSource administers one of the nation’s largest Medicaid
managed care plans and offers a lifetime of access to care through
health insurance, including Medicaid, Health Insurance Marketplace,
Medicare Advantage and dual-eligible programs. Headquartered in Dayton,
Ohio, CareSource serves nearly 2 million members in Georgia, Indiana,
Kentucky, Ohio and West Virginia. CareSource understands the challenges
consumers face navigating the health system and is transforming health
care with industry-leading programs that improve the health and
well-being of our members. For more, visit www.caresource.com,
follow @caresource on Twitter, or like CareSource on Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190613005229/en/
NANT
Jen Hodson
Jen@nant.com
562-397-3639
Source: NantHealth, Inc.